A science-trained heir charts SK’s biotech future beyond chips

SK heir Chey Yoon-chung is not one to stand still. “She likes to run and actively joins SK Biopharmaceuticals’ in-house running crew. She even competed in a company-wide rowing event," an industry official said of Chey, the eldest daughter of SK Group Chair Chey Tae-won. "During a business trip to the BIO International Convention 2025 in Boston last year, she ran at dawn with colleagues.” Such details offer a glimpse of a corporate heir who operates alongside employees rather than apart from the

By The Korea Herald